Viridian Therapeutics Inc
NASDAQ:VRDN

Watchlist Manager
Viridian Therapeutics Inc Logo
Viridian Therapeutics Inc
NASDAQ:VRDN
Watchlist
Price: 19.075 USD 0.24%
Market Cap: 1.5B USD
Have any thoughts about
Viridian Therapeutics Inc?
Write Note

P/S
Price to Sales

5 001.3
Current
700.8
Median
7.6
Industry
Higher than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
5 001.3
=
Market Cap
1.5B USD
/
Revenue
302k USD
All Countries
Close

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
4 664.8
2-Years Forward
P/S
6 383.5
3-Years Forward
P/S
37.7

See Also

Discover More